Bionure
Clinical stage biotech developing new drugs for CNS diseases.
8 employees · est. 2009 · Barcelona, Spain
GenSight Biologics
Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases
34 employees · est. 2013 · Paris, France
Bionure is the older company (2009 vs 2013); GenSight Biologics is the larger of the two.
Side-by-Side Comparison
| Metric | Bionure | GenSight Biologics |
|---|---|---|
| Founded | ||
| Founded | 2009 older | 2013 |
| Headquarters | ||
| Headquarters | Barcelona, Spain | Paris, France |
| Employees | ||
| Employees | 8 | 34 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Medical Devices | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $5.07M | $245.64M |
| Funding Rounds | ||
| Funding Rounds | 3 | 17 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biotech, Neurodegenerative Diseases, Clinical Stage, Drug Development, Neuroprotection, Remyelination, Orphan Designation, Ophthalmology, Rare Diseases, SGK Agonists, Optic Neuritis, Neuromyelitis Optica, Multiple Sclerosis, Neuro-inflammation, Clinical Trials | Clinical-stage Biotech, Gene Therapy, Retinal Diseases, Neurodegenerative Diseases, Mitochondrial Targeting Sequence, Optogenetics, Retinitis Pigmentosa, LHON, Gene Therapy-Based Treatments, Intravitreal Injection, Vision Restoration, Retinal Degeneration, Rare Diseases, Innovative Therapies |
| Website | ||
| Website | bionure.com | gensight-biologics.com |
About Bionure
Bionure is a clinical-stage biotech company focused on developing therapies for neurodegenerative diseases that currently lack treatment options. The company's lead candidate, BN201, is a first-in-class small molecule drug that has shown promising results in promoting neuroprotection and remyelinati...
About GenSight Biologics
GenSight Biologics is a biotechnology startup focused on developing groundbreaking therapies for severe retinal neurodegenerative diseases. Leveraging the Mitochondrial Targeting Sequence (MTS) and optogenetics, the company is striving to preserve or restore vision in patients with degenerative reti...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Bionure and GenSight Biologics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Bionure and GenSight Biologics — by email.
Frequently Asked Questions
Compare Bionure with someone else
Start typing a company name or domain.